Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 22196 [2015-09083]

Download as PDF 22196 Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices Arkansas for Medical Sciences, University of North Carolina at Chapel Hill, University of Minnesota, University of Wisconsin-Madison, Vanderbilt University, and Washington University in St. Louis. Four sites received funding to carry out Component A, which focuses on surveillance of ASD and either cerebral palsy or intellectual disability among 8year-olds. Six sites received funding to carry out both Component A as well as Component B, which focuses on surveillance of ASD among 4-year-olds. In addition to the sites funded under the cooperative agreement, CDC also administers a site in Atlanta, Georgia, commonly known as the Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP). CDC requests OMB approval to collect performance monitoring and program evaluation information from all sites participating in the Autism and Developmental Disabilities Monitoring Network (including the site administered by CDC). Over the course of the four-year funding cycle, each site will submit a Checklist, Worksheets, and Performance Measures every six month and two-year intervals. The Checklist, Worksheets, and Performance Measures will be submitted to CDC by completing a Microsoft Excel-based data collection tool and uploading the information to a secure, passwordprotected FTP site. By developing a user-friendly data collection tool in Microsoft Excel, CDC anticipates that the reporting and tracking burden for awardees will be reduced due to: (1) awardees’ familiarity with the software, which reduces training burden; and (2) the compatibility of the templates with other record keeping processes that are already in place for many awardees. CDC staff and contractors will be responsible for converting each awardee’s submissions into a secure Microsoft Access-based system for reporting and analysis. CDC anticipates that respondent burden will be slightly higher at the initial six-month submission and will also be slightly higher for sites completing Component A&B compared to just Component A. The information to be collected will help CDC and awardees assure compliance with cooperative agreement requirements, support program evaluation efforts, and obtain information needed to respond to inquiries about program activities and program impact from Congress and other stakeholders. OMB approval is requested for three years. Participation is required as a condition of cooperative agreement funding. There are no costs to respondents other than their time. The total estimated burden hours are 125. ESTIMATED ANNUALIZED BURDEN HOURS Number responses per respondent Number of respondents Average burden per response (in hours) Total burden hours Type of respondents Form name Component A only (initial six-month submission). Checklist ........................................... 5 1 3/60 1 Worksheets ...................................... Performance Measures .................... Checklist ........................................... 5 5 6 1 1 1 1.5 30/60 3/60 8 3 1 Worksheets ...................................... Performance Measures .................... Checklist ........................................... 6 6 5 1 1 5 2 4/60 3/60 12 4 1 Worksheets ...................................... Performance Measures .................... Checklist ........................................... 5 5 6 5 5 5 1 18/60 3/60 25 8 2 Worksheets ...................................... Performance Measures .................... 6 6 5 5 1.5 30/60 45 15 Component A&B (initial six-month submission). Component A only (subsequent sixmonth and two-year submissions). Component A&B (subsequent sixmonth and two-year submissions). Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–09087 Filed 4–20–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Effectiveness of Teen VerDate Sep<11>2014 19:23 Apr 20, 2015 Jkt 235001 Pregnancy Prevention Program Designed specifically for Young Males, DP15–007, initial review. SUMMARY: This document corrects a notice that was published in the Federal Register on April 14, 2015 Volume 80, Number 71, pages 19989. The title of the Special Emphasis Panel should read as above and time and date should read as follows: TIME AND DATE: 9:00 a.m.–6:00 p.m., April 7–8, 2015 (Closed). FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–09083 Filed 4–20–15; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 80, Number 76 (Tuesday, April 21, 2015)]
[Notices]
[Page 22196]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-09083]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Effectiveness of Teen 
Pregnancy Prevention Program Designed specifically for Young Males, 
DP15-007, initial review.
SUMMARY: This document corrects a notice that was published in the 
Federal Register on April 14, 2015 Volume 80, Number 71, pages 19989. 
The title of the Special Emphasis Panel should read as above and time 
and date should read as follows:

TIME AND DATE: 9:00 a.m.-6:00 p.m., April 7-8, 2015 (Closed).

FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta, 
Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-09083 Filed 4-20-15; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.